MUCOPRO Rebamipide 100mg Tablet 1's
- View all variations as list
CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
---|---|---|---|---|---|---|
RXDRUG-DRP-3797-02-1pc
|
In stock
|
₱2100 |
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
Sellers of this product
Features
- Rebamipide
Description
Indications/Uses
Dosage/Direction for Use
Gastric Ulcers: Usual Dose: 1 tablet orally 3 times daily.
Administration
Contraindications
Special Precautions
The safety of Rebamipide in pregnant women has not been established.
Nursing should be interrupted when this drug is administered.
Use in Children: The safety of this drug in children has not been established.
Use in Elderly: Special care should be given to elderly patients to minimize the risk of GI disorders because these patients maybe physiologically more sensitive to Rebamipide than younger patients.
Use In Pregnancy & Lactation
Use in Lactation: The safety of Rebamipide in pregnant women has not been established.
Adverse Reactions
Gastrointestinal: Dry mouth, constipations, sensation of abdominal enlargement, diarrhea, nausea, vomiting, heartburn, abdominal pain and belching may rarely occur.
Drug Interactions
Rebamipide can be safely given with the patients other anti-ulcer drugs.
Storage
Action
Distribution: Following single oral administration at 100 mg to 12 healthy individuals, plasma concentrations of Rebamipide reached the peak level (210 ng/mL) in 2 hrs.
Biotransformation: Rebamipide was primarily excreted as the unchanged compound in the urine when after single oral administration to healthy adult males at a dose of 600 mg.
Elimination: Approximately 10% of the administered dose was excreted in the urine when Rebamipide was administered once orally adult males at 100 mg.